Noncultured, Autologous, Skeletal Muscle Cells Can Successfully Engraft Into Ovine Myocardium
Open Access
- 24 June 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (24) , 3088-3092
- https://doi.org/10.1161/01.cir.0000070948.37545.e0
Abstract
Background— There is compelling evidence showing that cellular cardiomyoplasty can improve cardiac function. Considering the potential benefit of using noncultured muscle cells (little time, lower cost, reduced risk of contamination), we investigated the feasibility of grafting cells obtained directly after enzymatic dissociation of skeletal muscle biopsies into ovine myocardium. We hypothesized that those noncultured muscle cells would engraft massively. Methods and Results— Autologous, intramyocardial skeletal muscle cell implantation was performed in 8 sheep. A skeletal muscle biopsy sample (≈10 g) was explanted from each animal. The sheep were left to recover for ≈3 hours and reanesthetized when the cells were ready for implantation. A left fifth intercostal thoracotomy was performed, and 10 epicardial injections of the muscle preparation (between 10 and 20 million cells) were carried out. All sheep were euthanized 3 weeks after myocardial implantation. Immunohistochemistry was performed with monoclonal antibodies to a fast skeletal isoform of myosin heavy chain. Skeletal myosin heavy-chain expression was detected in all slides at 3 weeks after implantation in 8 of 8 animals, confirming engraftment of skeletal muscle cells. Massive areas of engraftment (from 2 to 9 mm in diameter) or discrete loci were noted within the myocardial wall. Conclusions— Our results indicate that noncultured skeletal muscle cells can successfully and massively engraft in ovine myocardium. Thus, avoiding the cell culture expansion phase is feasible and could become a promising option for cellular cardiomyoplasty.Keywords
This publication has 18 references indexed in Scilit:
- Cellular therapy reverses myocardial dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Cultured myf5 null and myoD null muscle precursor cells display distinct growth defectsBiology of the Cell, 2000
- Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathyThe Annals of Thoracic Surgery, 2000
- Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular functionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Autologous porcine heart cell transplantation improved heart function after a myocardial infarctionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Cellular Cardiomyoplasty Improves Diastolic Properties of Injured HeartJournal of Surgical Research, 1999
- Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998
- Skeletal myoblast transplantation for repair of myocardial necrosis.Journal of Clinical Investigation, 1996
- Cardiomyocyte Transplantation Improves Heart FunctionThe Annals of Thoracic Surgery, 1996